A recombinant Escherichia coli expressing an α-alkyl-β-ketoester reductase that yields the anti (2R,3R) α-alkyl-β-hydroxyester as the major product was constructed. The enzyme was identified from genomic libraries of Paucimonas lemoignei, cloned and expressed in E. coli providing a whole cell biocatalyst with novel stereoselectivity. This constitutes the first report on a whole cell biocatalyst for the synthesis of (2R,3R) α-alkyl-β-hydroxy-esters.
No takes yet. Share an insight, caveat, or question.
Panizza et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: